Protocadherin-7 (PCDH7) and protocadherin-9 (PCDH9) were identified and experimentally validated as targets of miR-155-3p and miR-155-5p, respectively, within primary glioma cells [101]. Here, PCDH7 is linked to central nervous system cancer.